pubmed-article:16983120 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16983120 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
pubmed-article:16983120 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
pubmed-article:16983120 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
pubmed-article:16983120 | lifeskim:mentions | umls-concept:C0079459 | lld:lifeskim |
pubmed-article:16983120 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
pubmed-article:16983120 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:16983120 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
pubmed-article:16983120 | lifeskim:mentions | umls-concept:C1883712 | lld:lifeskim |
pubmed-article:16983120 | lifeskim:mentions | umls-concept:C1099872 | lld:lifeskim |
pubmed-article:16983120 | pubmed:issue | 27 | lld:pubmed |
pubmed-article:16983120 | pubmed:dateCreated | 2006-9-19 | lld:pubmed |
pubmed-article:16983120 | pubmed:abstractText | To improve prognosis in children with acute myeloid leukemia (AML) by randomized comparisons of (1) two short consolidation cycles versus the Berlin-Frankfurt-Muenster (BFM) -type biphasic 6-week consolidation and (2) the prophylactic administration of granulocyte colony-stimulating factor (G-CSF) versus no G-CSF. Further, therapy for standard risk patients was intensified by addition of a second induction, HAM (high-dose cytarabine and mitoxantrone). | lld:pubmed |
pubmed-article:16983120 | pubmed:language | eng | lld:pubmed |
pubmed-article:16983120 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16983120 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16983120 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16983120 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16983120 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16983120 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16983120 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16983120 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16983120 | pubmed:month | Sep | lld:pubmed |
pubmed-article:16983120 | pubmed:issn | 1527-7755 | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:StittE SES | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:CreutzigUrsul... | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:GrafNorbertN | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:LehrnbecherTh... | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:RitterJörgJ | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:HermannJohann... | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:ReiterAlfredA | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:DworzakMichae... | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:ZimmermannMar... | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:NiemeyerCharl... | lld:pubmed |
pubmed-article:16983120 | pubmed:author | pubmed-author:ReinhardtDirk... | lld:pubmed |
pubmed-article:16983120 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:16983120 | pubmed:day | 20 | lld:pubmed |
pubmed-article:16983120 | pubmed:volume | 24 | lld:pubmed |
pubmed-article:16983120 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16983120 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16983120 | pubmed:pagination | 4499-506 | lld:pubmed |
pubmed-article:16983120 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:meshHeading | pubmed-meshheading:16983120... | lld:pubmed |
pubmed-article:16983120 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16983120 | pubmed:articleTitle | Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. | lld:pubmed |
pubmed-article:16983120 | pubmed:affiliation | Department of Hematology/Oncology, University Children's Hospital, Muenster, Germany. ursula@creutzig.de | lld:pubmed |
pubmed-article:16983120 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16983120 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:16983120 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:16983120 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:16983120 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16983120 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16983120 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16983120 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16983120 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16983120 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16983120 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16983120 | lld:pubmed |